Ledoxan

Ledoxan may be available in the countries listed below.

Ingredient matches for Ledoxan

Cyclophosphamide

Cyclophosphamide is reported as an ingredient of Ledoxan in the following countries:

• Philippines

International Drug Name Search

Nadolol

In the US, Nadolol (nadolol systemic) is a member of the drug class non-cardioselective beta blockers and is used to treat Angina, Anxiety, Benign Essential Tremor, Esophageal Variceal Hemorrhage Prophylaxis, Glaucoma, High Blood Pressure, Lithium Tremor, Migraine Prevention, Mitral Valve Prolapse, Parkinsonian Tremor and Supraventricular Tachycardia.

US matches:

• Nadolol


• Nadolol and bendroflumethiazide

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C07AA12

CAS registry number (Chemical Abstracts Service)

0042200-33-9

Chemical Formula

C17-H27-N-O4

Molecular Weight

309

Therapeutic Category

ß-Adrenergic blocking agent

Chemical Names

1-(tert-Butylamino)-3-[(5,6,7,8-tetrahydro-cis-6,7-dihydroxy-1-naphthyl)oxy]-2-propanol (WHO)

2,3-Naphthalenediol, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-

Foreign Names

• Nadololum (Latin)
• Nadolol (German)
• Nadolol (French)
• Nadolol (Spanish)

Generic Names

• Nadolol (OS: JAN, DCF, USAN, BAN)
• Nadololo (OS: DCIT)
• SQ 11725 (IS: Squibb)
• Nadolol (PH: BP 2010, JP XIV, USP 32, Ph. Eur. 6)
• Nadololum (PH: Ph. Eur. 6)

Brand Names

• Anabet
  Bristol-Myers Squibb, Portugal



• Apo-Nadol
  Apotex, Canada



• Apo-Nadolol
  Apotex, New Zealand



• Begen
  Tatsumi Kagaku, Japan



• Corgard
  Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Bahrain; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Kenya; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, Tanzania; Bristol-Myers Squibb, Uganda; Bristol-Myers Squibb, Venezuela; King, United States; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom



• Corzide (Nadolol and Bendroflumethiazide)
  King, United States



• Nadic
  Dainippon Sumitomo, Japan



• Nadolol and Bendroflumethazide (Nadolol and Bendroflumethazide)
  Impax, United States; Mylan, United States



• Nadolol
  Mylan, United States; Remedica, Cyprus; Sandoz, United States; Teva USA, United States; UDL, United States



• Naodoriru
  Tsuruhara Seiyaku, Japan



• Solgol
  Sanofi-Aventis S.A., Spain

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Reversair

Reversair may be available in the countries listed below.

Ingredient matches for Reversair

Montelukast

Montelukast sodium salt (a derivative of Montelukast) is reported as an ingredient of Reversair in the following countries:

• Bangladesh

International Drug Name Search

Nexterone

Nexterone is a brand name of amiodarone, approved by the FDA in the following formulation(s):

NEXTERONE (amiodarone hydrochloride - injectable; injection)

• 
  Manufacturer: BAXTER HLTHCARE
  
  Approval date: December 24, 2008
  
  Strength(s): 50MG/ML ^[AP]


• 
  Manufacturer: BAXTER HLTHCARE
  
  Approval date: November 16, 2010
  
  Strength(s): 150MG/100ML (1.5MG/ML) ^[RLD], 360MG/200ML (1.8MG/ML) ^[RLD]

Has a generic version of Nexterone been approved?

A generic version of Nexterone has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Nexterone and have been approved by the FDA:

amiodarone hydrochloride injectable; injection

• 
  Manufacturer: HIKMA FARMACEUTICA
  
  Approval date: February 25, 2008
  
  Strength(s): 50MG/ML ^[AP]


• 
  Manufacturer: WOCKHARDT
  
  Approval date: October 30, 2008
  
  Strength(s): 50MG/ML ^[AP], 50MG/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nexterone. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
  Patent 6,869,939
  Issued: March 22, 2005
  Inventor(s): Mosher; Gerold L. & Johnson; Karen T. & Gayed; Atef A.
  Assignee(s): CyDex, Inc.
  The present invention provides aqueous parenteral formulations containing an antiarrhythmic agent, such as amiodarone, and a sulfoalkyl ether cyclodextrin. The liquid formulations are clear, sterilizable, and chemically and physically stable. The liquid formulations do not require a surfactant and do not precipitate upon dilution with distilled water or other pharmaceutically acceptable liquid carrier. The sulfoalkyl ether cyclodextrin-containing formulation provides significant advantages over other cyclodextrin-containing formulations of amiodarone. The formulation can be prepared in acidic, neutral and slightly basic medium while providing acceptable concentrations of amiodarone suitable for parenteral administration. An SAE-CD-containing formulation of amiodarone can be provided in liquid form or as a reconstitutable powder. Moreover, highly concentrated solutions exceeding 200 mg of amiodarone per mL can be prepared. Solutions can be made either dilutable or non-dilutable with water at room temperature or under conditions typically encountered in the clinic.
  
  Patent expiration dates:
  
  
  • May 4, 2022
    
    ✓ 
    Drug product
  
  



• 
  Sulfoalkyl ether cyclodextrin compositions
  Patent 7,635,773
  Issued: December 22, 2009
  Inventor(s): Antle; Vincent
  Assignee(s): CyDex Pharmaceuticals, Inc.
  SAE-CD compositions are provided, along with methods of making and using the same. The SAE-CD composition comprises a sulfoalkyl ether cyclodextrin and less than 100 ppm of a phosphate, wherein the SAE-CD composition has an absorption of less than 0.5 A.U. due to a drug-degrading agent, as determined by UV/vis spectrophotometry at a wavelength of 245 nm to 270 nm for an aqueous solution containing 300 mg of the SAE-CD composition per mL of solution in a cell having a 1 cm path length.
  
  Patent expiration dates:
  
  
  • March 13, 2029
    
    ✓ 
    Drug product
  
  

See also...

• Nexterone Consumer Information (Drugs.com)
• Nexterone Solution Consumer Information (Wolters Kluwer)
• Nexterone injection Consumer Information (Cerner Multum)
• Amiodarone Consumer Information (Drugs.com)
• Amiodarone Consumer Information (Wolters Kluwer)
• Amiodarone Solution Consumer Information (Wolters Kluwer)
• Amiodarone Consumer Information (Cerner Multum)
• Amiodarone injection Consumer Information (Cerner Multum)
• Amiodarone Intravenous Advanced Consumer Information (Micromedex)
• Amiodarone Intravenous, Oral Advanced Consumer Information (Micromedex)
• Amiodarone Hydrochloride AHFS DI Monographs (ASHP)

Craveril

Craveril may be available in the countries listed below.

Ingredient matches for Craveril

Fenofibrate

Fenofibrate is reported as an ingredient of Craveril in the following countries:

• Argentina

International Drug Name Search

Adco-Metrostat

Adco-Metrostat may be available in the countries listed below.

Ingredient matches for Adco-Metrostat

Metronidazole

Metronidazole is reported as an ingredient of Adco-Metrostat in the following countries:

• South Africa

International Drug Name Search

Dextromethorphan Freezer Pops

Pronunciation: DEX-troe-meth-OR-fan
Generic Name: Dextromethorphan
Brand Name: PediaCare Long-Acting Cough

Dextromethorphan Freezer Pops are used for:

Temporarily relieving cough due to the common cold, hay fever, upper respiratory tract infections, sinus inflammation, sore throat, or bronchitis.

Dextromethorphan Freezer Pops are a cough suppressant. It works in the cough center of the brain to reduce a dry or nonproductive cough.

Do NOT use Dextromethorphan Freezer Pops if:

• you are allergic to any ingredient in Dextromethorphan Freezer Pops


• you have taken furazolidone or a monoamine oxidase (MAO) inhibitor (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dextromethorphan Freezer Pops:

Some medical conditions may interact with Dextromethorphan Freezer Pops. Tell your health care provider if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of chronic cough, asthma, lung problems (eg, chronic bronchitis, emphysema), chronic obstructive pulmonary disease (COPD), or if cough occurs with a large amount of mucus

Some MEDICINES MAY INTERACT with Dextromethorphan Freezer Pops. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Furazolidone or MAO inhibitors (eg, phenelzine) because the risk of serious side effects, such as severe low blood pressure, fever, severe muscle problems, and possibly death, may be increased by Dextromethorphan Freezer Pops

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dextromethorphan Freezer Pops may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dextromethorphan Freezer Pops:

Use Dextromethorphan Freezer Pops as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Dextromethorphan Freezer Pops may be taken with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• To use, cut off the top of the freezer pop sleeve and push freezer pop up from the bottom. Dextromethorphan Freezer Pops may be eaten frozen or the contents of 1 unfrozen sleeve may be poured into a cup or glass to drink. Immediately throw away any unused portion of the opened medicine.


• If you miss a dose of Dextromethorphan Freezer Pops and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dextromethorphan Freezer Pops.

Important safety information:

• Dextromethorphan Freezer Pops may cause drowsiness, dizziness, blurred vision, or lightheadedness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Dextromethorphan Freezer Pops. Using Dextromethorphan Freezer Pops alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.


• If your cough lasts for more than 1 week or comes back, or if you also have a fever, rash, or persistent headache, contact your doctor. A persistent cough could be a sign of a serious condition.


• Dextromethorphan Freezer Pops contains dextromethorphan. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains dextromethorphan. If it does or if you are not sure, contact your doctor or pharmacist.


• Diabetes patients - Some brands of Dextromethorphan Freezer Pops may contain sugar and affect your blood sugar level. Read the label carefully before using Dextromethorphan Freezer Pops.


• Dextromethorphan Freezer Pops are not recommended for use in CHILDREN younger than 2 years of age. Safety and effectiveness in this age group have not been confirmed.


• PREGNANCY and BREAST-FEEDING: It is unknown if Dextromethorphan Freezer Pops can cause harm to the fetus. If you become pregnant while taking Dextromethorphan Freezer Pops, discuss with your doctor the benefits and risks of using Dextromethorphan Freezer Pops during pregnancy. It is unknown if Dextromethorphan Freezer Pops are excreted in breast milk. Do not breast-feed while taking Dextromethorphan Freezer Pops.

Possible side effects of Dextromethorphan Freezer Pops:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dizziness; drowsiness; stomach upset.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dextromethorphan side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include confusion; excitement; hallucinations; slowed breathing.

Proper storage of Dextromethorphan Freezer Pops:

Store Dextromethorphan Freezer Pops at 77 degrees F (25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dextromethorphan Freezer Pops out of the reach of children and away from pets.

General information:

• If you have any questions about Dextromethorphan Freezer Pops, please talk with your doctor, pharmacist, or other health care provider.


• Dextromethorphan Freezer Pops are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dextromethorphan Freezer Pops. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dextromethorphan resources

• Dextromethorphan Side Effects (in more detail)
• Dextromethorphan Use in Pregnancy & Breastfeeding
• Dextromethorphan Drug Interactions
• Dextromethorphan Support Group
• 8 Reviews for Dextromethorphan - Add your own review/rating

Compare Dextromethorphan with other medications

• Cough